Tag: Recordati S.p.A

July 3, 2017 Off

AstraZeneca completes two commercial rights deals, payments included in Q2 2017

AstraZeneca on Monday reported closing two different agreements for certain commercial rights for its drugs, in Europe and worldwide.

May 22, 2017 Off

AstraZeneca in agreement with Recordati S.p.A for certain commercial rights

By Dino Mustafić

AstraZeneca has entered into an agreement with Recordati S.p.A for the commercial rights to Seloken/Seloken ZOK (metoprolol tartrate and metoprolol succinate respectively) and associated Logimax fixed-dose combination (metoprolol succinate and felodipine) treatments in Europe.